Search research articles
Contact Us
Filters
Showing results (21-30 of 159) with videos related to
Page
of 16
Sort By:
Molecular Cancer
|
January 29, 2010
The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia
Jasmin R Agarwal, Frank Griesinger, Walter Stühmer, et al.
Journal of Cancer Research and Clinical Oncology
|
July 6, 2014
Superior vena cava syndrome caused by a malignant tumor: a retrospective single-center analysis of 124 cases
Karin Hohloch, Nick Bertram, Lorenz Trümper, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 16, 2004
Secondary leukaemia after cure for locally advanced NSCLC: alkylating type secondary leukaemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB
Frank Griesinger, Michael Metz, Lorenz Trümper, et al.
Onkologie
|
September 16, 2006
[Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)]
Wilfried Eberhardt, Rainer Fietkau, Frank Griesinger, et al.
Journal of Comparative Effectiveness Research
|
February 25, 2022
Health technology assessments and real-world evidence: tell us what you want, what you really, really want
Frank Griesinger, Oliver Cox, Cormac Sammon, et al.
International Journal of Environmental Research and Public Health
|
August 12, 2022
Needs of Lung Cancer Patients Receiving Immunotherapy and Acceptance of Digital and Sensor-Based Scenarios for Monitoring Symptoms at Home-A Qualitative-Explorative Study
Milena von Kutzleben, Jan Christoph Galuska, Andreas Hein, et al.
Haematologica
|
September 2, 2011
Managing individuals with propensity to myeloid malignancies due to germline RUNX1 deficiency
Tim Ripperger, Marcel Tauscher, Detlef Haase, et al.
Journal of Cancer Research and Clinical Oncology
|
May 9, 2022
Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach
Fabienne Englmeier, Annalen Bleckmann, Wolfgang Brückl, et al.
Journal of Cancer Research and Clinical Oncology
|
March 10, 2012
Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study
Mirko Nitsche, Hans Christiansen, Katinka Lederer, et al.
Oncotarget
|
November 13, 2018
Brain metastases in ALK-positive NSCLC - time to adjust current treatment algorithms
Frank Griesinger, Julia Roeper, Christoph Pöttgen, et al.
Page
of 16
Search research articles
Search
Showing results (21-30 of 159) with videos related to
Sort By:
Page
of 16
Molecular Cancer
|
January 29, 2010
The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia
Jasmin R Agarwal, Frank Griesinger, Walter Stühmer, et al.
Journal of Cancer Research and Clinical Oncology
|
July 6, 2014
Superior vena cava syndrome caused by a malignant tumor: a retrospective single-center analysis of 124 cases
Karin Hohloch, Nick Bertram, Lorenz Trümper, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 16, 2004
Secondary leukaemia after cure for locally advanced NSCLC: alkylating type secondary leukaemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB
Frank Griesinger, Michael Metz, Lorenz Trümper, et al.
Onkologie
|
September 16, 2006
[Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)]
Wilfried Eberhardt, Rainer Fietkau, Frank Griesinger, et al.
Journal of Comparative Effectiveness Research
|
February 25, 2022
Health technology assessments and real-world evidence: tell us what you want, what you really, really want
Frank Griesinger, Oliver Cox, Cormac Sammon, et al.
International Journal of Environmental Research and Public Health
|
August 12, 2022
Needs of Lung Cancer Patients Receiving Immunotherapy and Acceptance of Digital and Sensor-Based Scenarios for Monitoring Symptoms at Home-A Qualitative-Explorative Study
Milena von Kutzleben, Jan Christoph Galuska, Andreas Hein, et al.
Haematologica
|
September 2, 2011
Managing individuals with propensity to myeloid malignancies due to germline RUNX1 deficiency
Tim Ripperger, Marcel Tauscher, Detlef Haase, et al.
Journal of Cancer Research and Clinical Oncology
|
May 9, 2022
Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach
Fabienne Englmeier, Annalen Bleckmann, Wolfgang Brückl, et al.
Journal of Cancer Research and Clinical Oncology
|
March 10, 2012
Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study
Mirko Nitsche, Hans Christiansen, Katinka Lederer, et al.
Oncotarget
|
November 13, 2018
Brain metastases in ALK-positive NSCLC - time to adjust current treatment algorithms
Frank Griesinger, Julia Roeper, Christoph Pöttgen, et al.
Page
of 16